Other von Willebrand disease
ICD-10 D68.09 is a billable code used to indicate a diagnosis of other von willebrand disease.
Other von Willebrand disease (D68.09) refers to a group of bleeding disorders characterized by a deficiency or dysfunction of von Willebrand factor (vWF), a crucial protein for platelet adhesion and aggregation. This condition can lead to excessive bleeding, particularly in response to injury or surgical procedures. Unlike classic von Willebrand disease, which is classified into types 1, 2, and 3 based on severity and vWF levels, 'other' von Willebrand disease encompasses atypical forms that may not fit neatly into these categories. Patients may present with symptoms such as easy bruising, prolonged bleeding from cuts, heavy menstrual periods, and spontaneous bleeding episodes. Diagnosis typically involves laboratory tests to measure vWF levels and activity, platelet function assays, and sometimes genetic testing. Management may include desmopressin administration, vWF concentrates, and supportive care to prevent and control bleeding episodes. Understanding the nuances of this condition is essential for accurate coding and appropriate patient management.
Comprehensive lab results, patient history, and treatment plans.
Patients presenting with unexplained bleeding, pre-operative assessments for bleeding risk.
Ensure clarity in distinguishing between types of von Willebrand disease and other bleeding disorders.
Detailed patient history, family history of bleeding disorders, and referral notes to specialists.
Routine evaluations of patients with a history of bleeding or bruising.
Documenting referrals and follow-up care is crucial for continuity of care.
Used to evaluate bleeding disorders including von Willebrand disease.
Document the reason for the CBC and any relevant clinical findings.
Hematologists may require additional tests to confirm diagnosis.
D68.09 refers to other forms of von Willebrand disease that do not fit into the defined types, while D68.0 specifically refers to type 1 von Willebrand disease, which has a more defined clinical presentation and laboratory criteria.
